How GLP-1 and GIP May Support Medical Weight Loss

weight loss image, woman standing on a scale

Weight management is influenced by much more than willpower. Appetite signals, hormones, metabolism, medications, sleep, health conditions and genetics can all affect how the body regulates hunger and weight.

For some adults, a provider-directed medical weight-loss program may include medication that acts on the GLP-1 pathway or both the GLP-1 and GIP pathways. These treatments are designed to work alongside nutrition, physical activity and sustainable lifestyle changes rather than replace them.

What Is GLP-1?

GLP-1 stands for glucagon-like peptide-1. It is a naturally occurring hormone released by the digestive system in response to food.

GLP-1 helps communicate with areas of the body involved in appetite, digestion and blood-sugar regulation. Medications that act on GLP-1 receptors imitate some of these natural signals.

Depending on the patient and prescribed treatment, GLP-1 activity may help:

  • Reduce feelings of hunger
  • Support a longer-lasting sense of fullness
  • Decrease food intake
  • Slow the movement of food through the stomach
  • Support glucose-dependent insulin activity
  • Make it easier to follow an individualized nutrition plan

Responses vary considerably. Medication does not eliminate the need for balanced nutrition, movement, sleep and appropriate medical follow-up.

What Is GIP?

GIP stands for glucose-dependent insulinotropic polypeptide. Like GLP-1, it is an incretin hormone released after eating and involved in the body’s response to nutrients.

Some medical weight-loss treatments act on both GIP and GLP-1 receptors. This dual-pathway approach may influence appetite, food intake and metabolic signaling through complementary mechanisms.

A licensed provider considers the patient’s medical history, treatment goals, current medications and relevant risk factors when determining whether a GLP-1 or dual GIP/GLP-1 treatment may be appropriate.

Potential Benefits of Provider-Directed Treatment

When medically appropriate, treatment that acts on GLP-1 or combined GIP/GLP-1 pathways may support a structured weight-management plan by helping some patients experience less hunger and greater fullness.

Potential benefits may include:

  • Improved appetite regulation
  • Reduced food cravings or preoccupation with food
  • Better portion awareness
  • Greater ability to follow a nutrition plan
  • Support for gradual weight reduction
  • Improvements in certain weight-related health measurements

These are potential benefits, not promised outcomes. The amount and rate of weight change differ from person to person, and some patients may not respond as expected.

Medical Weight Loss Is More Than Medication

Medication is one possible part of a broader weight-management strategy. Long-term progress also depends on habits and health factors that medication alone cannot address.

A thoughtful plan may include:

  • Adequate protein and nutrient intake
  • Appropriate calorie and portion guidance
  • Regular physical activity
  • Strength or resistance training
  • Hydration
  • Consistent sleep
  • Stress management
  • Monitoring for side effects
  • Periodic provider follow-up

Rapidly eating less without attention to nutrition may make it difficult to consume enough protein, vitamins, minerals or fluids. Your provider may recommend dietary adjustments or additional monitoring based on your needs.

How Telehealth Evaluation Works

Treatment through Elevate Integrative Wellness begins with a secure medical questionnaire and telehealth evaluation.

A licensed healthcare provider reviews information that may include your:

  • Current weight and weight-management goals
  • Medical and surgical history
  • Current medications and supplements
  • Allergies
  • Previous weight-loss treatments
  • Relevant gastrointestinal, pancreatic or endocrine history
  • Pregnancy or breastfeeding status
  • Other factors that may affect treatment safety

The provider may approve treatment, request laboratory testing or medical records, recommend another option or determine that telehealth treatment is not appropriate.

Purchasing a program and completing an evaluation do not guarantee approval or a prescription.

Patient-Specific Compounded Medication

If treatment is approved and a compounded medication is prescribed, the prescription is sent to a licensed compounding pharmacy authorized to dispense in the patient’s state.

The pharmacy prepares the patient-specific compounded medication according to the licensed provider’s prescription. The provider and pharmacy determine the formulation, strength, dosage, administration instructions and treatment schedule.

Compounded medications are not FDA-approved. This means the FDA does not review an individual compounded medication for safety, effectiveness or manufacturing quality before it is marketed in the same manner as an FDA-approved medication.

Compounded treatment should be used only when prescribed for an identified patient and determined to be medically appropriate. Patients should follow the exact instructions supplied by the provider and dispensing pharmacy.

Side Effects and Safety Considerations

GLP-1 and dual GIP/GLP-1 treatments are not appropriate for everyone. Commonly reported side effects may include nausea, vomiting, diarrhea, constipation, reduced appetite and abdominal discomfort.

A provider should review your medical history and current medications before treatment. Contact your provider if side effects are persistent, worsening or difficult to manage.

Seek urgent medical attention for severe abdominal pain, signs of a serious allergic reaction, severe dehydration or another potentially serious reaction.

Never change your dosage, dosing frequency or injection amount without instructions from your prescribing provider. Do not share prescription medication with another person.

Setting Realistic Expectations

Medical weight loss is an individualized process. Progress may be influenced by the selected treatment, dosage, tolerance, consistency, nutrition, activity, sleep, health conditions and other medications.

The purpose of provider-directed care is not to promise a particular number on the scale. It is to determine whether treatment may be appropriate, monitor safety and help the patient pursue realistic health goals.

Is GLP-1 or GIP/GLP-1 Treatment Right for You?

The answer requires an individual medical evaluation. A licensed provider can review your history, discuss potential risks and benefits, and determine whether prescription treatment may be appropriate.

Elevate Integrative Wellness offers a convenient telehealth process for eligible adults interested in exploring provider-directed medical weight loss.

Explore Weight-Loss Options

This article is for general educational purposes and is not medical advice. Prescription treatment requires evaluation and approval by a licensed healthcare provider. Treatment availability is subject to provider discretion, pharmacy requirements, state regulations and current product availability. Individual results are not guaranteed.

More Posts

Find More Articles